Le Loët X - Search Results

1

VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85).

Mineur P, Ménard JF, Le Loët X, Bernard JF, Grosbois B, Pollet JP, Azais I, Laporte JP, Doyen C, De Gramont A, Wetterwald M, Euller-Ziegler L, Peny AM, Monconduit M, Michaux JL. Mineur P, et al. Among authors: le loet x. Br J Haematol. 1998 Nov;103(2):512-7. doi: 10.1046/j.1365-2141.1998.00997.x. Br J Haematol. 1998. PMID: 9827927 Free article. Clinical Trial.

2

Combination chemotherapy with vincristine, doxorubicin, dexamethasone for refractory or relapsing multiple myeloma.

Monconduit M, Le Loet X, Bernard JF, Michaux JL. Monconduit M, et al. Among authors: le loet x. Br J Haematol. 1986 Jul;63(3):599-601. doi: 10.1111/j.1365-2141.1986.tb07538.x. Br J Haematol. 1986. PMID: 3730288 No abstract available.

3

VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM).

Monconduit M, Menard JF, Michaux JL, Le Loet X, Bernard JF, Grosbois B, Pollet JP, Azais I, Laporte JP, Doyen C, et al. Monconduit M, et al. Among authors: le loet x. Br J Haematol. 1992 Feb;80(2):199-204. doi: 10.1111/j.1365-2141.1992.tb08901.x. Br J Haematol. 1992. PMID: 1550777 Clinical Trial.

4

[Multiple myeloma in 1990].

Le Loët X, Monconduit M, Euller-Ziegler L. Le Loët X, et al. Ann Med Interne (Paris). 1990;141(2):108-10. Ann Med Interne (Paris). 1990. PMID: 2191611 Review. French. No abstract available.

5

[Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma].

Le Loët X, Monconduit M, Menard JF, Deshayes P, Grobois B, Tanguy A, Prevost E, Piguet H. Le Loët X, et al. Rev Rhum Mal Osteoartic. 1984 May;51(5):263-7. Rev Rhum Mal Osteoartic. 1984. PMID: 6740189 French.

6

Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM).

Mejjad O, Le Loët X, Basuyau JP, Ménard JF, Jego P, Grisot C, Daragon A, Grosbois B, Euller-Ziegler L, Monconduit M. Mejjad O, et al. Among authors: le loet x. Eur J Haematol. 1996 Jan-Feb;56(1-2):30-4. Eur J Haematol. 1996. PMID: 8599990

7

[Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion].

Monconduit M, Le Loët X, Bernard JF, Menard JF, Grosbois B, Michaux JL, De Gramont A, Laporte JP, Najman A, Jouet JP, et al. Monconduit M, et al. Among authors: le loet x. Rev Rhum Mal Osteoartic. 1987 Jun;54(6):477-9. Rev Rhum Mal Osteoartic. 1987. PMID: 3616472 French. No abstract available.

8

Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM).

Daragon A, Humez C, Michot C, Le Loet X, Grosbois B, Pouyol F, Euller-Ziegler L, Azais I, Bernard JF, Menard JF, et al. Daragon A, et al. Among authors: le loet x. Eur J Med. 1993 Oct-Nov;2(8):449-52. Eur J Med. 1993. PMID: 8258043 Clinical Trial.

9

[Mental nerve neuropathy in myeloma].

Le Loet X, Menard JF, Daragon A, Deshayes P. Le Loet X, et al. Presse Med. 1985 Dec 28;14(46):2346. Presse Med. 1985. PMID: 3003733 French. No abstract available.

10

Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.

Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X. Vittecoq O, et al. Among authors: le loet x. Rheumatology (Oxford). 2003 Aug;42(8):939-46. doi: 10.1093/rheumatology/keg257. Epub 2003 Apr 16. Rheumatology (Oxford). 2003. PMID: 12730503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters